Law

Welcome to Business Den, your go-to source for legal news in Denver. Our coverage is informative and engaging, keeping you up-to-date on the latest legal developments in the Mile High City. Whether you’re a legal professional, a law student, or simply someone interested in the legal happenings of Denver, our page has something for you.

Subscribe to Business Den today and stay ahead of the curve.

Disgraced doctor sues Westword

Currently on probation and stripped of his medical license, a former hospital director has filed a lawsuit against the local alternative paper for republishing defamatory claims about him.

Founding partner leaves law firm

The founder of a personal injury firm has left the company behind, citing a differing vision for the firm’s future.

Chambers of commerce clash over logo

The region’s largest chamber of commerce is taking a new cannabis chamber to court, claiming that the new organization’s logo infringes on its copyright.

Former pilot sues Frontier

An Army veteran and former pilot for the Denver-based airline is taking the company to court over claims it illegally refused to hire him back after a deployment.

Energy law firms unite

An eight-employee energy firm based on Larimer Street is merging with a larger Texas firm with a local office in the Wells Fargo Center.

Longtime lawyers to retire, close firm

After 25 years in business and work with big-name clients, a Denver law firm is shutting down as its two founders ready to retire.

Mall fortune heiress sues IRS for $21M

A Carbondale woman and widow of a real estate billionaire filed a suit in Denver this week against the U.S. government. Her $21 million claim stems from an agreement that her late husband made in order to walk away from ownership of a struggling NBA team.

Korean newspapers grapple in court

The papers are taking their rivalry to court after one called the competing publication’s publisher “a person with a dual personality.”

Medical firm hit with class-action suit

A Castle Rock medical firm was sued by its shareholders last week over allegedly misleading them about a pending FDA ruling on the company’s primary product.